MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

Home・Akcijų sąrašas・Celldex Therapeutics Inc

Celldex Therapeutics Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

31 -0.9

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

30.32

Max

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-14M -81M
Pardavimai	75K 75K
Pelnas, tenkantis vienai akcijai	-1.22
Pelno marža	-108,422.667
Darbuotojai	198
EBITDA	-7.8M -81M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+72.46% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-05-06

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	346M 2B
Ankstesnė atidarymo kaina	31.9
Ankstesnė uždarymo kaina	31

Naujienos nuotaikos

By Acuity

100%

335 / 349 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

18.91 / 20.63 Palaikymas ir pasipriešinimas

Celldex Therapeutics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-04-02 17:11; UTC

Pagrindinės rinkos jėgos

Svarbiausios naujienos

Home Depot Shares Hit 52-Week Low as Iran War Threatens Housing Rebound

2026-04-02 17:10; UTC

Svarbiausios naujienos

ECB's Next Move Likely a Rate Rise, But Timing Unclear Amid Iran War, Villeroy Says

2026-04-03 00:00; UTC

Svarbiausios naujienos

How Insulated Is the U.S. Economy From the Iran War? -- WSJ

2026-04-02 23:47; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Nikkei Might Rise After Thursday's Selloffs -- Market Talk

2026-04-02 21:05; UTC

Įsigijimai, susijungimai, perėmimai

Starbucks: Under the Terms of the Agreement, Funds Managed by Boyu Cap Now Hold a 60% Stake in Starbucks China Retail Ops >SBUX

2026-04-02 21:05; UTC

Įsigijimai, susijungimai, perėmimai

Starbucks: Retains 40% Ownership Interest and Continues to Own and License the Brand and Intellectual Property to JV >SBUX

2026-04-02 21:05; UTC

Įsigijimai, susijungimai, perėmimai

Starbucks: Joint Venture Is Designed to Enhance Starbucks Ability to Expand Footprint, Deepen Local Relevance >SBUX

2026-04-02 21:05; UTC

Įsigijimai, susijungimai, perėmimai

Starbucks and Boyu Cap: Finalize Joint Venture to Accelerate Long-Term Growth in China

2026-04-02 21:01; UTC

Svarbiausios naujienos

Investors Waver after Trump Speech on Iran, Ending Two-Day Surge in Stocks -- WSJ

2026-04-02 20:59; UTC

Įsigijimai, susijungimai, perėmimai

Starbucks and Boyu Capital Finalize China JV

2026-04-02 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-04-02 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-04-02 20:41; UTC

Uždarbis

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2026-04-02 20:32; UTC

Rinkos pokalbiai

Higher Gas Prices Intensify K-Shaped Economy -- Market Talk

2026-04-02 20:30; UTC

Įsigijimai, susijungimai, perėmimai

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2026-04-02 20:09; UTC

Rinkos pokalbiai

Eli Lilly On More Equal Footing With Rival With Weight-Loss Pill -- Market Talk

2026-04-02 20:01; UTC

Įsigijimai, susijungimai, perėmimai

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2026-04-02 19:46; UTC

Rinkos pokalbiai

Is Oil the New GameStop? -- Market Talk

2026-04-02 19:35; UTC

Rinkos pokalbiai

U.S. Natural Gas Falls As Storage Injection Season Gets Under Way -- Market Talk

2026-04-02 19:29; UTC

Įsigijimai, susijungimai, perėmimai

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2026-04-02 19:24; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Futures Jump Ahead of Long Weekend -- Market Talk

2026-04-02 19:20; UTC

Rinkos pokalbiai

Nike Has Yet to Show That a Turnaround is on Horizon -- Market Talk

2026-04-02 19:01; UTC

Įsigijimai, susijungimai, perėmimai

Union Pacific: ATDA Agreement to Guarantee Jobs for Life for Union Employees After Norfolk Southern Deal

2026-04-02 19:00; UTC

Įsigijimai, susijungimai, perėmimai

Union Pacific: Agreement Reached With American Train Dispatchers Association

2026-04-02 18:24; UTC

Įsigijimai, susijungimai, perėmimai

Globalstar Stock Rises on Amazon Deal Report. Why Apple Could Scuttle the Launch. -- Barrons.com

2026-04-02 17:44; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Supply Squeeze Puts Refiners in a Quandary -- Market Talk

2026-04-02 17:32; UTC

Svarbiausios naujienos

Amazon to Boost Fuel Surcharges on Third-Party Sellers as Costs Rise -- Barrons.com

2026-04-02 17:26; UTC

Uždarbis

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2026-04-02 17:17; UTC

Rinkos pokalbiai

Shares of Canadian Exports Heading to U.S. Continues to Slide -- Market Talk

2026-04-02 17:09; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Holds Gains After Trump Speech Disappointed Market -- Market Talk

Akcijų palyginimas

Kainos pokytis

Celldex Therapeutics Inc Prognozė

Kainos tikslas

By TipRanks

72.46% į viršų

12 mėnesių prognozė

Vidutinis 53.91 USD 72.46%

Aukščiausias 90 USD

Žemiausias 24 USD

Remiantis 12 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Celldex Therapeutics Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

12 ratings

Pirkti

Laikyti

Parduoti

Remiantis 12 analitikų, pateikusių Celldex Therapeutics Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

18.91 / 20.63Palaikymas ir pasipriešinimas

Recent bullish events outweigh bearish events.

All events are bearish.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Celldex Therapeutics Inc

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.